Black Diamond Therapeutics to Participate in Upcoming Investor Conferences Mar 2, 2026 04:01PM
TD Cowen Reiterates Buy Rating on Black Diamond Therapeutics (BDTX) Sep 23, 2024 02:19PM
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference Feb 28, 2024 08:00AM
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference Feb 27, 2023 08:00AM
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference Feb 27, 2023 08:00AM


Mar 2, 2022 08:00AM Black Diamond Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference
Mar 2, 2022 08:00AM Black Diamond Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference
Feb 23, 2021 07:45AM Black Diamond Therapeutics to Present at Upcoming Investor Conferences
Feb 23, 2021 07:45AM Black Diamond Therapeutics to Present at Upcoming Investor Conferences
Feb 24, 2020 04:30PM Black Diamond Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 24, 2020 04:30PM Black Diamond Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 24, 2020 06:33AM UPDATE: Cowen Starts Black Diamond Therapeutics (BDTX) at Outperform
Feb 3, 2020 04:30PM Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Feb 3, 2020 04:30PM Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Feb 3, 2020 04:30PM Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Jan 30, 2020 11:08AM Black Diamond Therapeutics (BDTX) IPO Opens 74% Higher
Jan 30, 2020 05:53AM Black Diamond Therapeutics (BDTX) Prices 10.586M Share IPO at $19/Sh
Jan 29, 2020 07:33PM Black Diamond Therapeutics Announces Pricing of Initial Public Offering
Jan 29, 2020 07:33PM Black Diamond Therapeutics Announces Pricing of Initial Public Offering